AMAT Shares Plunge 30% in a Month: Should You Buy, Sell or Hold?

Applied Materials shares fell 30.3% in a month amid a broader semiconductor-equipment sell-off and concerns about AI investment returns and near-term supply constraints; AMAT trades at 8.52x sales versus 3.14x for its industry. The company reported fiscal Q3 AGS revenue of $1.78 billion, up 22% year over year, with operating margin up 280 basis points, and expects advanced-packaging revenue to grow more than 70% in 2026. Zacks recommends holding the stock, citing AI-related equipment demand and services growth alongside valuation and execution risks.

Analysis

The key tension is conversion, not demand: advanced-node and HBM spending can remain strategically necessary while supplier constraints delay tool shipments, revenue recognition, and customer ramp productivity. That makes near-term results vulnerable even if multi-year fab plans hold. Capacity expansion across the supply chain could release this bottleneck over coming quarters, but it may also shift bargaining power back toward customers if tool supply catches up faster than fab utilization.

AGS provides a partial shock absorber: a larger installed base and demand for uptime/yield services should make revenue less sensitive than new-system orders. It is not a full hedge, however—delayed fab ramps can defer service intensity and weaken the utilization-led case. The 8.52x sales multiple leaves AMAT exposed to further de-rating if estimates finally follow the share price lower; unchanged earnings estimates are not proof of a floor and may reflect revision lag.

Contrarian read: the drawdown may be discounting an AI-capex air pocket before cancellations appear, but it may also overstate the structural damage if spending is delayed rather than abandoned. Over the next 1–3 months, watch order conversion, shipment commentary, and estimate revisions. Over 6–18 months, the test is whether the expanded capacity and installed-base services translate into realized growth without margin dilution. A persistent estimate-cut cycle or customer capex retrenchment would invalidate the recovery case.

Key Decisions for Investors

• Avoid an immediate full-size dip buy. Consider a staged AMAT entry only after management commentary or reported results confirm that supply constraints are easing into shipments and earnings estimates stabilize.
• For a relative-value expression, consider a small, beta-controlled long AMAT/short LRCX pair only if subsequent disclosures show better AMAT shipment conversion while LRCX remains more constrained. Reassess if the supply bottleneck proves industry-wide or AMAT guidance weakens; the recent relative share moves alone do not establish mispricing.
• Keep existing AMAT exposure but hedge some semiconductor-equipment beta rather than treating AGS growth as insulation from a WFE downturn. Reduce or exit if order softness drives repeated consensus cuts, or if service growth and margin expansion fail to persist.
• Track customer capex plans, AMAT system shipments versus orders, AGS growth and margins, and supplier lead times. These are the missing checks needed to distinguish temporary timing slippage from a genuine AI-investment reset.